Decision ensures millions of Americans living with diabetes will have access to affordable, quality care….

Now that ADA is over there has been a lot of press about the use of newer medications for more aggressively treating elevated A1c’s. In addition there were numerous presentations on “not yet approved” treatments in the pipeline. This week our Homerun Slides give you a great overview of these …

Diet and Nutritional Strategies During Sport and Exercise in Type 1 Diabetes Elaine Hibbert-Jones and Gill Regan             Exercise means different things to different people and for competitive sport involves many hours of training.

  Part 1 of this two-part series covers some of the newest therapies for type 2 diabetes including GLP-1 agonists and DPP-4 inhibitors. We also take a look at some of the even newer therapies on the horizon such as SGLT2 inhibitors, ultra long-acting insulin (degludec) and interleukin-1 blocker, diacerein.